PRA Health Sciences

PRA-Health-Sciences.png

PRA is a global drug development partner providing strategies and solutions spanning every stage of asset development. Today, we are consistently ranked among the top CROs and best employers in the world, all while striving to reinvent healthcare research tomorrow.

PRA helps develop lifesaving and life-improving drugs with our comprehensive clinical development services, including data management, statistical analysis, clinical trial management, medical writing, and regulatory and drug development consulting. We’re committed to leveraging our expertise and cutting-edge technology in order to expand the possibilities of traditional clinical drug development – and beyond. 

Latest Content

Related Resources

Global Pediatric Drug Development Collaboration: Part One

Global Pediatric Drug Development Collaboration: Part One

Content provided by PRA Health Sciences

White Paper

The pharmaceutical industry is unlike any other industry in that the products manufactured can dramatically improve, and even save, lives. This is especially the case when it comes to children. Although pediatric patients comprise a smaller population of...

Global Pediatric Drug Development Collaboration: Part Two

Global Pediatric Drug Development Collaboration: Part Two

Content provided by PRA Health Sciences

White Paper

70% of medicines given to children have never been studied in pediatric populations. Children who need treatments represent a relatively small population. This alone presents unique challenges for pediatric drug development. Since the 1990s, authorities...